Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.54419 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.52812 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.53865 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.45645 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.50395 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.06442 | 42 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.52804 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.5204 | 23 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.53614 | 24 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.5221 | 23 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.51323 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.6324 | 29 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.50818 | 22 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.7035 | 31 |